These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

551 related items for PubMed ID: 24692173

  • 1. Differential role of TIMP2 and TIMP3 in cardiac hypertrophy, fibrosis, and diastolic dysfunction.
    Fan D, Takawale A, Basu R, Patel V, Lee J, Kandalam V, Wang X, Oudit GY, Kassiri Z.
    Cardiovasc Res; 2014 Jul 15; 103(2):268-80. PubMed ID: 24692173
    [Abstract] [Full Text] [Related]

  • 2. Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress.
    Kandalam V, Basu R, Moore L, Fan D, Wang X, Jaworski DM, Oudit GY, Kassiri Z.
    Circulation; 2011 Nov 08; 124(19):2094-105. PubMed ID: 21986284
    [Abstract] [Full Text] [Related]

  • 3. TIMP3 is the primary TIMP to regulate agonist-induced vascular remodelling and hypertension.
    Basu R, Lee J, Morton JS, Takawale A, Fan D, Kandalam V, Wang X, Davidge ST, Kassiri Z.
    Cardiovasc Res; 2013 Jun 01; 98(3):360-71. PubMed ID: 23524300
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
    Zhong J, Basu R, Guo D, Chow FL, Byrns S, Schuster M, Loibner H, Wang XH, Penninger JM, Kassiri Z, Oudit GY.
    Circulation; 2010 Aug 17; 122(7):717-28, 18 p following 728. PubMed ID: 20679547
    [Abstract] [Full Text] [Related]

  • 5. Fibrosis or hypertrophy: let TIMPs decide.
    Westermann D, Heymans S.
    Cardiovasc Res; 2014 Jul 15; 103(2):196-7. PubMed ID: 24957072
    [No Abstract] [Full Text] [Related]

  • 6. TIMP2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation.
    Kandalam V, Basu R, Abraham T, Wang X, Soloway PD, Jaworski DM, Oudit GY, Kassiri Z.
    Circ Res; 2010 Mar 05; 106(4):796-808. PubMed ID: 20056917
    [Abstract] [Full Text] [Related]

  • 7. Interferon-γ ablation exacerbates myocardial hypertrophy in diastolic heart failure.
    Garcia AG, Wilson RM, Heo J, Murthy NR, Baid S, Ouchi N, Sam F.
    Am J Physiol Heart Circ Physiol; 2012 Sep 01; 303(5):H587-96. PubMed ID: 22730392
    [Abstract] [Full Text] [Related]

  • 8. SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy.
    Tang X, Chen XF, Wang NY, Wang XM, Liang ST, Zheng W, Lu YB, Zhao X, Hao DL, Zhang ZQ, Zou MH, Liu DP, Chen HZ.
    Circulation; 2017 Nov 21; 136(21):2051-2067. PubMed ID: 28947430
    [Abstract] [Full Text] [Related]

  • 9. Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy.
    Matsui Y, Jia N, Okamoto H, Kon S, Onozuka H, Akino M, Liu L, Morimoto J, Rittling SR, Denhardt D, Kitabatake A, Uede T.
    Hypertension; 2004 Jun 21; 43(6):1195-201. PubMed ID: 15123578
    [Abstract] [Full Text] [Related]

  • 10. Adiponectin deficiency, diastolic dysfunction, and diastolic heart failure.
    Sam F, Duhaney TA, Sato K, Wilson RM, Ohashi K, Sono-Romanelli S, Higuchi A, De Silva DS, Qin F, Walsh K, Ouchi N.
    Endocrinology; 2010 Jan 21; 151(1):322-31. PubMed ID: 19850745
    [Abstract] [Full Text] [Related]

  • 11. Deficiency of senescence marker protein 30 exacerbates angiotensin II-induced cardiac remodelling.
    Misaka T, Suzuki S, Miyata M, Kobayashi A, Shishido T, Ishigami A, Saitoh S, Hirose M, Kubota I, Takeishi Y.
    Cardiovasc Res; 2013 Aug 01; 99(3):461-70. PubMed ID: 23723062
    [Abstract] [Full Text] [Related]

  • 12. Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling.
    Izumiya Y, Kim S, Izumi Y, Yoshida K, Yoshiyama M, Matsuzawa A, Ichijo H, Iwao H.
    Circ Res; 2003 Oct 31; 93(9):874-83. PubMed ID: 14551246
    [Abstract] [Full Text] [Related]

  • 13. IRF3 regulates cardiac fibrosis but not hypertrophy in mice during angiotensin II-induced hypertension.
    Tsushima K, Osawa T, Yanai H, Nakajima A, Takaoka A, Manabe I, Ohba Y, Imai Y, Taniguchi T, Nagai R.
    FASEB J; 2011 May 31; 25(5):1531-43. PubMed ID: 21266535
    [Abstract] [Full Text] [Related]

  • 14. Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice.
    Wang AW, Song L, Miao J, Wang HX, Tian C, Jiang X, Han QY, Yu L, Liu Y, Du J, Xia YL, Li HH.
    Am J Hypertens; 2015 Apr 31; 28(4):518-26. PubMed ID: 25362112
    [Abstract] [Full Text] [Related]

  • 15. Myocardial overexpression of TIMP3 after myocardial infarction exerts beneficial effects by promoting angiogenesis and suppressing early proteolysis.
    Takawale A, Zhang P, Azad A, Wang W, Wang X, Murray AG, Kassiri Z.
    Am J Physiol Heart Circ Physiol; 2017 Aug 01; 313(2):H224-H236. PubMed ID: 28550172
    [Abstract] [Full Text] [Related]

  • 16. Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction.
    Ainscough JF, Drinkhill MJ, Sedo A, Turner NA, Brooke DA, Balmforth AJ, Ball SG.
    Cardiovasc Res; 2009 Feb 15; 81(3):592-600. PubMed ID: 18703536
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling.
    Weisberg AD, Albornoz F, Griffin JP, Crandall DL, Elokdah H, Fogo AB, Vaughan DE, Brown NJ.
    Arterioscler Thromb Vasc Biol; 2005 Feb 15; 25(2):365-71. PubMed ID: 15576638
    [Abstract] [Full Text] [Related]

  • 18. TIMP3 deficiency exacerbates iron overload-mediated cardiomyopathy and liver disease.
    Zhabyeyev P, Das SK, Basu R, Shen M, Patel VB, Kassiri Z, Oudit GY.
    Am J Physiol Heart Circ Physiol; 2018 May 01; 314(5):H978-H990. PubMed ID: 29373036
    [Abstract] [Full Text] [Related]

  • 19. Elevated intracardiac angiotensin II leads to cardiac hypertrophy and mechanical dysfunction in normotensive mice.
    Huggins CE, Domenighetti AA, Pedrazzini T, Pepe S, Delbridge LM.
    J Renin Angiotensin Aldosterone Syst; 2003 Sep 01; 4(3):186-90. PubMed ID: 14608525
    [Abstract] [Full Text] [Related]

  • 20. Lysyl oxidase overexpression accelerates cardiac remodeling and aggravates angiotensin II-induced hypertrophy.
    Galán M, Varona S, Guadall A, Orriols M, Navas M, Aguiló S, de Diego A, Navarro MA, García-Dorado D, Rodríguez-Sinovas A, Martínez-González J, Rodriguez C.
    FASEB J; 2017 Sep 01; 31(9):3787-3799. PubMed ID: 28522596
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.